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Abstract
Background—Preoperative magnetic resonance imaging (MRI) use has increased among older 
women diagnosed with breast cancer. MRI detects additional malignancy, but its impact on 
locoregional surgery and radiation treatment remains unclear.
Methods—We examined the associations of preoperative MRI with initial locoregional treatment 
type (mastectomy, breast conserving surgery (BCS) with radiation therapy (RT), BCS without RT) 
and BCS reoperation rates for SEER-Medicare women diagnosed with stage 0–III breast cancer 
from 2005–2009 (N=55,997).
Results—We found no association of initial locoregional treatment of mastectomy (OR 1.04, 
95% CI (0.98–1.11)) or reoperation after initial BCS (OR 0.96, 95% CI (0.89–1.03)) between 
women with preoperative MRI (16.2%) compared to women without MRI. However, women with 
MRI who had initial BCS were more likely to undergo RT (OR 1.09 (1.02–1.16)).
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Conclusion—Preoperative breast MRI in Medicare-enrolled women with stage 0–III breast 
cancer was not associated with increased mastectomy. However, in older women with MRI 
undergoing BCS, there was a greater use of RT.
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Introduction
Preoperative breast magnetic resonance imaging (MRI) use has increased in breast cancer 
treatment planning for women with invasive cancer and ductal carcinoma in situ (DCIS). (1) 
Previous SEER-Medicare studies report a dramatic increase in preoperative MRI use in 
older women diagnosed in 2005 (10%) to 25% – 50% in 2008/2009 (1–5), and a recent 
Canadian study reported close to 15% of women diagnosed with breast cancer in Ontario, 
Canada received a preoperative MRI. The same study noted that preoperative MRI was 
associated with aggressive surgical interventions. (6) Despite the increasing trend in MRI 
utilization, the value of preoperative MRI is widely debated. (7) While MRI is more 
sensitive than mammography and finds additional otherwise-occult malignancy in 
approximately 16% of women in the ipsilateral breast, the evidence has yet to show clinical 
benefit of preoperative MRI and the downstream associated treatments. (8, 9) This 
uncertainty is seen in conflicting guidelines around appropriate use of preoperative MRI. 
The current guidelines from the National Comprehensive Cancer Network (NCCN) 
recommend preoperative MRI as optional for DCIS and invasive cancer. (10) The European 
Society of Breast Cancer Specialists (EUSOMA) recommendations state that acceptable 
indications for preoperative MRI include a diagnosis of invasive lobular carcinoma, a 
discrepancy greater than 1 cm between mammography and ultrasound size with expected 
impact on treatment, and consideration for partial breast irradiation. (11) The ACR Practice 
Guidelines for MRI of the Breast, state that preoperative MRI may be useful to determine 
extent of disease. (12)
The impact of preoperative MRI on the surgical management of women newly diagnosed 
with breast cancer continues to be poorly understood. Multiple single-institution studies 
have shown that preoperative MRI is associated with increased mastectomy rates. (13–15) 
Sommer et al. found higher mastectomy rates for Medicare-enrolled women (N=46,824) 
from 2003–2005 who received preoperative MRI (40.8%) as compared to those who did not 
(38.8%) (p=.04).(4) Prior studies have shown conflicting results on the ability of MRI to 
decrease reoperation rates, diminish ipsilateral breast tumor recurrence, or improve survival. 
(9)
Because the relationship of MRI use to types of treatment remain unclear, our objective was 
to evaluate the association between preoperative MRI use and locoregional surgical and 
radiation treatment of breast cancer among women diagnosed with Stage 0–III breast cancer 
enrolled in Medicare fee for service. Additionally, in women with initial BCS, we 
investigated the impact of preoperative MRI on reoperation.
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We used the Surveillance, Epidemiology and End Results (SEER)-Medicare database 
(2004–2010), which combines clinical and sociodemographic information from population-
based cancer registries with claims information from records of Medicare beneficiaries with 
cancer.(16) The SEER-Medicare database is a collaboration of the National Cancer Institute 
(NCI), the SEER registries and the Centers for Medicare and Medicaid Services (CMS), (17) 
and includes records from 1.8 million people with cancer (233,000 with breast cancer).
Study Population
We included women in the SEER Medicare database diagnosed with non-metastatic breast 
cancer (DCIS (Stage 0) or Stage I–III invasive breast cancer) between 2005 and 2009 who 
received a mastectomy or BCS (with or without radiation therapy) within six months after 
their breast cancer diagnosis. Women were included if they were 66 years or older at the 
time of their breast cancer diagnosis, and had a pathologically confirmed diagnosis as 
defined by SEER. (10) To ensure complete claims data capture, we included women enrolled 
in Medicare Part A (Hospital Insurance) and Medicare Part B (Medical Insurance) Fee-For-
Service plans from one year prior to six months following breast cancer diagnosis. We 
excluded women with a prior personal history of breast cancer and those whose source of 
diagnosis was a nursing home.
Definitions
Current Procedural Terminology (CPT)/Healthcare Common Procedure Coding System 
(HCPCS) and International Classification of Diseases (ICD-9) diagnosis and procedure 
codes (Supplemental Table 1) from the Outpatient and Carrier Medicare claims files were 
used to identify the biopsy closest to the time of diagnosis, the initial surgical treatment, 
reoperation following an initial BCS, and preoperative MRI use. As described in a previous 
publication (1), because SEER does not capture exact diagnosis date, the breast cancer 
diagnosis date was defined as the breast biopsy date closest to the SEER diagnosis date or 
the first day of the month of the SEER diagnosis date if a biopsy claim was not found 
(approximately 3% of women). The preoperative window was limited to a maximum of six 
months from the date of breast cancer diagnosis to the date of the first breast surgery found 
in claims. We defined the initial locoregional treatments as mastectomy or BCS with or 
without RT. Reoperation after initial BCS was a secondary outcome, defined as a second 
surgery (BCS or mastectomy) within 6 months after the initial BCS. Receipt of preoperative 
MRI within the preoperative window was our primary exposure of interest. (1)
Analysis
We compared the distribution of surgical treatment types, including reoperation, by 
diagnosis year among those with and without MRI. Differences in MRI utilization across the 
study period were assessed using a chi-square test.
Separate unadjusted and multivariable logistic regression models estimated odds ratios for 
initial treatment type (mastectomy vs. BCS; among those treated with BCS: RT vs. no RT, 
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and reoperation within 6 months following initial BCS vs. no reoperation), in relation to 
receipt of MRI. Model results are reported as crude and adjusted odds ratios (OR) with 95% 
confidence intervals (95% CI). Models were adjusted for patient, tumor, and hospital 
characteristics. Comorbidities were defined using the Klabunde adaptation of the Charlson 
Index (18). We calculated the median and interquartile range of the number of days to 
reoperation by type of reoperation surgery (mastectomy or BCS) to compare MRI groups. 
For all analyses, we used SAS 9.4 SAS (SAS Institute Inc. 2015. SAS® 9.4 System Options: 
Reference, Fourth Edition. Cary, NC: SAS Institute Inc.).
Results
Among the 55,997 women in the SEER Medicare database with stage 0–III breast cancer 
diagnosed from 2005 to 2009, preoperative MRI was performed on 9,055 women (16.2%). 
For initial locoregional treatment, 20,793 women (37.1%) received a mastectomy and 
35,204 (62.9%) received BCS. Of the women receiving initial BCS, 61.2% (N = 21,545) had 
BCS with RT and 38.8% (N = 13,659) had BCS without RT. Table 1 and Table 2 show the 
distribution of patient, tumor and hospital characteristics for the sample overall, by initial 
treatment type, and by reoperation following initial BCS. Additional patient and tumor 
characteristics are provided in Supplemental Table 2.
Preoperative MRI increased from 7% in 2005 to 24% in 2009 (p<0.0001). Calendar year 
trends in initial locoregional treatment types for women with and without MRI are displayed 
in Figure 1a (mastectomy vs BCS) and Figure 1b (among women with initial BCS: RT v no 
RT and reoperation). The proportions of women receiving mastectomy compared to BCS 
ranged from 39% in 2005 to 38% in 2009 in the no MRI group and from 38% in 2005 to 
32% in 2009 for the MRI group (Figure 1a). Of women who had initial BCS, the proportions 
with RT compared to no RT were higher in the MRI group. There were no differences in 
reoperation following initial BCS between the MRI groups and no MRI groups over the 
study period (Figure 1b).
Preoperative MRI and surgical treatment type of mastectomy vs. BCS showed lower odds of 
receiving a mastectomy among women receiving MRI (OR 0.84 (95% CI (0.80–0.88)). 
However, in the adjusted model, we found no association (OR 1.04 (95% CI (0.98–1.11)) 
(Table 3). Mastectomy was most strongly associated with older age, rural residence, lower 
income, Medicaid enrollment, comorbidities, high grade, stage II or III, nodal and ER status, 
large tumors, invasive lobular histology (compared to invasive ductal), non-teaching 
hospitals, and cancer or other hospitals (compared to general hospital), as shown in Figure 2.
For women treated with initial BCS (N=35,204), women who received preoperative MRI 
were significantly more likely to receive RT than those who did not receive MRI (OR 1.45 
95% CI (1.37–1.54)). This association remained after adjustment (OR 1.09 95% CI (1.02– 
1.16); Table 3). Young age, urban residence, high income, few comorbidities, small tumors, 
and surgery occurring in a general or cancer hospital (compared to ‘other’ hospital types) 
were factors associated with BCS with RT (Figure 2). Additionally, a reoperation was 
performed in 7,268 women (20.6%) among those whose initial treatment was BCS. The 
unadjusted and adjusted models found no association between MRI and odds of reoperation 
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(Table 3). Factors associated with a reoperation included young age, DCIS and invasive 
lobular (compared to invasive ductal), large tumors and non-cancer and other hospitals 
(Figure 2). A median of 28 days (IQR 19–42 days) for a reoperation of a mastectomy for 
women undergoing preoperative MRI vs. 28 days (IQR 15–44 days) without MRI was 
calculated. Similarly, time to reoperation of a BCS was 14 days (IQR 9–25 days) for women 
with preoperative MRI vs. 16 days (IQR 9–28 days) without MRI.
Discussion
In Medicare-enrolled women with stage 0–III breast cancer diagnosed from 2005 to 2009, 
preoperative MRI increased in frequency. However, the increase was not associated with an 
increase in mastectomy rates over the time. Of note, we found significantly higher rates of 
post-BCS RT among women who had preoperative MRI. This is the first study of 
preoperative breast MRI in older women in the U.S. to identify no associated increase in 
mastectomies and the first to evaluate frequencies of RT after BCS related to MRI use. 
These patterns do not necessarily imply causality, but are important findings, as we better 
understand treatment patterns around preoperative MRI.
There have been several recently published studies evaluating trends in preoperative MRI 
use and associations between preoperative MRI and surgical treatment of breast cancer. 
Most recently, Arnaout et al. (6) published a Canadian population-based study of women 
with stage 1–III breast cancers from 2003 to 2012, and reported increasing MRI use and 
greater frequency of mastectomy with MRI (OR, 1.73; 95% CI, 1.62–1.85). Their study 
included women at younger ages and within a closed health system, which may explain their 
mastectomy results. Killelea, et al. used SEER-Medicare data from 2000 to 2009, and 
reported a significant increase in preoperative breast MRI use and a greater rate of bilateral 
mastectomies in the preoperative MRI group.(3) However, they looked at women with stage 
I–III breast cancers. In this group of women, they reported that in their adjusted model, MRI 
was associated with a significantly higher rate of mastectomy in women with MRI 
(compared to BCS (adjusted OR =1.21 (95% CI (1.14–1.28)), but did not look at association 
between MRI and receipt of RT in women with BCS.
We found no difference in the frequencies of reoperation in women undergoing initial BCS 
who had MRI compared to those who did not have MRI. We found that factors associated 
with a reoperation included young age, DCIS and invasive lobular and large tumors. Prior 
observational studies and randomized controlled trials (RCTs) have evaluated the association 
between preoperative MRI use and reoperation rates among women who received BCS as 
their initial surgery. Using Medicare data from 2002–2007, Wang, et al. (19) evaluated the 
associations between preoperative breast MRI and multiple breast surgeries for 45,453 
women aged 66 and older with stage 0–II cancer. 20.8% of these patients received multiple 
breast surgeries. While the researchers uncovered substantial variation in the rates of 
multiple surgeries in these women and large variation between individual surgeons, they 
found no significant differences in the rate of multiple surgeries between the two groups 
with or without preoperative breast MRI, suggesting preoperative breast MRI does not 
reduce the risk of receiving multiple surgeries.
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Grouping women by histologic type, Fortune-Greeley, A.K., et al. examined whether there 
were differential benefits from preoperative breast MRI according to histology. (20) They 
examined the surgical outcomes—initial mastectomy, reoperation, and final mastectomy 
rates—among 20,333 women diagnosed with early-stage breast cancer from 2004–2007 in 
SEER-Medicare, 12.2% of whom had a preoperative breast MRI. They classified women as 
having invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), mixed ductal/
lobular carcinoma (IDLC) or other histologic type. Their study provided evidence in support 
of the targeted use of preoperative breast MRI among patients with ILC to improve surgical 
planning; however, it did not find breast MRI to be significantly associated with a likelihood 
of a reoperation overall or among patients with IDC and IDLC, but was associated with 
greater odds of a final mastectomy.
Our study adds to the above studies in a number of ways. In contrast to prior studies, we 
found no increase in initial mastectomy frequency with preoperative breast MRI. There are 
several reasons why our results may differ from those of other investigations. We included a 
wider range of breast cancer stages at diagnosis, from 0–III, and examined these trends in 
older women only, with data from 2005 through 2009. Most previous studies have not 
included stage 0 cancers, and included older data starting prior to 2005. We also explored 
whether women with initial BCS received RT and report a positive association between MRI 
and RT. This is an important consideration when trying to understand the downstream effects 
of preoperative MRI. RT is generally considered the standard-of-care following BCS 
because it decreases local recurrence rates for both DCIS and invasive cancer. However, the 
NCCN guidelines state that it may be omitted in patients >= 70 years of age with T1, node 
negative and ER positive breast cancer who receive adjuvant endocrine therapy. Our results 
showing an increase of use of RT could be a marker of more appropriate care in women who 
are choosing BCS. However, it is also possible that patients and providers electing MRI 
prefer a more intensive treatment strategy. For example, physicians who routinely use 
preoperative MRI may be more likely to recommend RT following BCS. Alternatively, it is 
possible that women who receive MRI are motivated to seek more treatment for their breast 
cancer. This raises the question of whether MRI is changing the ultimate surgical procedure 
or if MRI is an indicator of more intensive interventions in general.
Limitations
Although we were able to account for a number of potential confounders, we were unable to 
control for all characteristics that may be associated with breast MRI and our outcomes, 
such as physician specific factors or patient preferences. We had no information on planned 
treatment course before or after preoperative MRI, so are unable to evaluate the influence of 
the MRI on ultimate treatment received, but are aware of no population-based data that can 
do this. Additionally, selection bias may exist for MRI and intensive treatment that is not 
related to what is observed on MRI, such as our finding that MRI is associated with RT 
women undergoing BCS. The SEER-Medicare dataset contains a large amount of data at the 
population level, which allows us to uncover national trends in the relationship of MRI and 
BCS, but it has several limitations. Notably, it does not include several clinical variables that 
may have informed the indications for ordering preoperative MRIs, such as breast density, 
multicentric disease, family history, BRCA mutations, or women’s preferences. These 
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variables will be important to include in future analyses. Our population of women was 66 
years or older at the time of their diagnosis and our findings may not be generalizable to 
younger women, who are more likely to receive preoperative breast MRI. (19) In spite of 
these limitations, we believe that the study’s considerable strengths outweigh the 
weaknesses.
Implications
To inform decision making regarding preoperative MRI use for breast cancer treatment, the 
potential impact on locoregional surgical and radiation therapy approaches need to be 
understood. MRI is supported by some as a useful tool in preoperative assessment, 
particularly in subsets of women such as those with denser breasts or those with invasive 
lobular carcinoma. (10) (11) (21) However, evidence to support its broad use is lacking. If 
MRI is finding additional disease, and if modifying treatment patterns accordingly will 
improve patient outcomes, then neglecting to use MRI is a missed opportunity. However, 
using MRI in lower-risk women is likely to increase the number of biopsies and may 
increase overtreatment. One major concern is whether using MRI is leading to unnecessary 
mastectomies. Our results mitigate concerns about unnecessary MRI-associated 
mastectomies in the older population, and may indicate MRI has an impact on decisions 
regarding RT. Our findings also suggest that preoperative MRI may be used differently for 
different age groups.
Conclusion
Preoperative MRI use continues to increase in older women diagnosed with breast cancer, 
with almost a quarter of women receiving MRI in recent years. Medicare-enrolled women 
receiving preoperative MRI are most likely to receive BCS with RT as the rate of 
mastectomy has decreased in recent years. Given the increasing trend in utilization of 
preoperative MRI, further analyses are imperative to determine the impact on long-term 
patient outcomes such as recurrence and survival.
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Refer to Web version on PubMed Central for supplementary material.
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Preoperative breast MRI in Medicare-enrolled women with stage 0–III breast cancer was 
not associated with increased mastectomy. However, we found among older women with 
MRI undergoing BCS there was a greater use of RT. The results mitigate concerns about 
unnecessary MRI-associated mastectomies in this population, and raise the question of 
whether MRI is changing the initial locoregional surgical or radiation treatment or if MRI 
is an indicator of more intensive interventions in general.
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Figure 1a Percent of surgery type (mastectomy v BCS) by diagnostic year among SEER 
Medicare women (N=55,997) diagnosed with non-metastatic breast cancer (2005–2009) 
with (N=9,055) and without (N=46,942) MRI
Abbreviations: MRI = Magnetic Resonance Imaging; BCS= Breast Conserving Surgery.
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Figure 1b Among women with an initial BCS, percent of surgery type (RT vs. no RT) and 
reoperation by diagnostic year among SEER Medicare women (N=55,997) diagnosed with 
non-metastatic breast cancer (2005–2009) with (N=9,055) and without (N=46,942) MRI
Abbreviations: MRI = Magnetic Resonance Imaging; BCS= Breast Conserving Surgery; RT 
= Radiation Therapy.
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Odds ratios (OR) and 95% confidence intervals (95% CI) for the initial surgery type 
(Mastectomy vs. BCS; BCS RT vs. BCS no RT) and reoperation after initial BCS vs. no 
reoperation by MRI use, patient, tumor and hospital characteristics among SEER Medicare 
women (N=55,997) diagnosed with non-metastatic breast cancer (2005–2009)
Abbreviations: MRI = Magnetic Resonance Imaging; BCS= Breast Conserving Surgery; RT 
= Radiation Therapy; DX=Diagnosis; Inv =Invasive; NCI COOP = National Cancer Institute 
Cooperative Oncology Group Member.
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